loadpatents
name:-0.018608808517456
name:-0.014224052429199
name:-0.0065000057220459
Varsolona; Richard J. Patent Filings

Varsolona; Richard J.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Varsolona; Richard J..The latest application filed is for "process for the preparation of 2-fluoroadenine".

Company Profile
2.15.17
  • Varsolona; Richard J. - Scotch Plains NJ
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Process For The Preparation Of 2-fluoroadenine
App 20220242866 - Chung; John Y.L. ;   et al.
2022-08-04
Crystalline form of a BACE inhibitor, compositions, and use
Grant 11,306,080 - Artino , et al. April 19, 2
2022-04-19
Solid Forms Of Ceftolozane And Processes For Preparing
App 20220056045 - Maloney; Kevin Matthew ;   et al.
2022-02-24
Crystalline Forms of 1-[(3R,4S)-4-Cyanotetrahydropyran-3-YL]-3-[(2-Fluoro-6-Methoxy-4-Pyridyl)- Amino]Pyrazole-4-Carboxamide
App 20220024902 - Chassaing; Christophe Pierre Alain ;   et al.
2022-01-27
A Novel Crystalline Form Of A Bace Inhibitor, Compositions, And Use
App 20200199117 - Artino; Laura M. ;   et al.
2020-06-25
Process for preparing substituted tetracyclic heterocycle compounds
Grant 10,457,690 - Yin , et al. Oc
2019-10-29
Process For Preparing Substituted Tetracyclic Heterocycle Compounds
App 20180179223 - Yin; Jingjun ;   et al.
2018-06-28
Solid State Forms Of A Potent Hcv Inhibitor
App 20140057928 - BRICKL; Rolf-Stefan ;   et al.
2014-02-27
Solid state forms of a potent HCV inhibitor
Grant 8,598,183 - Brickl , et al. December 3, 2
2013-12-03
Crystalline forms of a potent HCV inhibitor
Grant 8,362,035 - Berkenbusch , et al. January 29, 2
2013-01-29
Crystalline Forms Of A Potent Hcv Inhibitor
App 20120270775 - BERKENBUSCH; Thilo ;   et al.
2012-10-25
Crystalline forms of a potent HCV inhibitor
Grant 8,232,293 - Berkenbusch , et al. July 31, 2
2012-07-31
Solid State Forms Of A Potent Hcv Inhibitor
App 20120122887 - BRICKL; Rolf-Stefan ;   et al.
2012-05-17
Crystalline Forms Of A Potent Hcv Inhibitor
App 20100093792 - BERKENBUSCH; Thilo ;   et al.
2010-04-15
Synthesis of 6,7-Dihydro-5H-imidazo[1,2-a]imidazole-3-sulfonic acid amides
App 20090088571 - WANG; Xiao-jun ;   et al.
2009-04-02
Synthesis of 6,7-dihydro-5H-imidazo[1,2-a]imidazole-3-sulfonic acid amides
Grant 7,470,795 - Wang , et al. December 30, 2
2008-12-30
Synthesis of 6,7-dihydro-5H-imidazo[1,2-a]imidazole-3-sulfonic acid amides
App 20060025447 - Wang; Xiao-Jun ;   et al.
2006-02-02
Dihydroxy open-acid salt of simvastatin
App 20050119343 - Tillyer, Richard D. ;   et al.
2005-06-02
Crystalline phases of a potent HCV inhibitor
App 20040229777 - Cerreta, Michael Kenneth ;   et al.
2004-11-18
Gamma-hydroxy-2-(fluoroalkylaminocarbonyl)-1-piperazinepentanamides and uses thereof
Grant 6,642,237 - Tata , et al. November 4, 2
2003-11-04
Dihydroxy open-acid salt of simvastatin
App 20030176501 - Tillyer, Richard D. ;   et al.
2003-09-18
Therapeutic polymorphs of a GABA-A alpha-5 inverse agonist and pamoate formulations of the same
App 20010049439 - Kaufman, Michael J. ;   et al.
2001-12-06
HIV protease inhibitor
Grant 6,071,916 - Askin , et al. June 6, 2
2000-06-06
Finasteride processes
Grant 5,886,184 - Dolling , et al. March 23, 1
1999-03-23
Pyrazinone thrombin inhibitors
Grant 5,866,573 - Sanderson , et al. February 2, 1
1999-02-02
Polymorphic forms of a growth hormone secretagogue
Grant 5,767,124 - Draper , et al. June 16, 1
1998-06-16
Process for the production of finasteride
Grant 5,652,365 - McCauley , et al. July 29, 1
1997-07-29

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed